Boothbay Fund Management’s Immunovant, Inc. Warrants expiring 12/18/2024 IMVTW Stock Holding History

Boothbay Fund Management’s Portfolio IMVTW Stock Details IMVTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-442,201	Closed	-$6.88M	–	1195
2020 Q1	$6.88M	Sell	442,201 -268,358	-38%	-$515K	0.57%	25
2019 Q4	$11.3M	Buy	+710,559	New	+$1.44M	0.98%	6

Boothbay Fund Management's IMVTW Position: Q2 2020 in Review

Boothbay Fund Management sold out of Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) in Q2 2020, closing a stake of 442,201 shares — an estimated $6.88M sold.

Boothbay Fund Management first reported a position in IMVTW in Q4 2019 and held it in 2 quarters. The position peaked at $11.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold IMVTW as of Q2 2020.

Boothbay Fund Management reported no remaining Immunovant, Inc. Warrants expiring 12/18/2024 position as of Q2 2020 after selling out during the quarter.
Boothbay Fund Management sold 442,201 Immunovant, Inc. Warrants expiring 12/18/2024 shares in Q2 2020, an estimated $6.88M.
Boothbay Fund Management first reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 in Q4 2019 and held it in 2 quarters.
Boothbay Fund Management's Immunovant, Inc. Warrants expiring 12/18/2024 position peaked at $11.3M in Q4 2019.
0 funds tracked by Wall St. Rank held Immunovant, Inc. Warrants expiring 12/18/2024 as of Q2 2020.

Based on Boothbay Fund Management's 13F filing for Q2 2020, filed 14 Aug 2020.